M. Cuartero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Cuartero has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Antoni Jordi Betbesé
Universitat Autónoma de Barcelona
2 shared publications J. Baldirà
Intensive Care Department and Institut d'Investigacions Biomèdiques, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
1 shared publicationJ. Ordonez-Llanos
Biochemistry Department and Institut d'Investigacions Biomèdiques, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
1 shared publication- J. Sabater
Intensive Care Department, Hospital Universitari Bellvitge, Hospitalet de Llobregat, Universitat de Barcelona, Feixa Llarga, 08907, L’Hospitalet de Llobregat, Barcelona, Spain
1 shared publication - Jordi Ordóñez-Llanos
Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
1 shared publication - Josep Ballus
Intensive Care Department, Hospital Universitari Bellvitge, Hospitalet de Llobregat, Universitat de Barcelona, Feixa Llarga, 08907, L’Hospitalet de Llobregat, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 2 May 2019
- Published by Wiley in Disease Markers
- Vol. 2019, 1-9
Does Whole-Blood Neutrophil Gelatinase-Associated Lipocalin Stratify Acute Kidney Injury in Critically Ill Patients?
Purpose. To analyse the capacity of whole-blood NGAL (wbNGAL) to stratify AKI in critically ill patients with and without sepsis. Methods. Whole-blood NGAL was measured with a point-of-care device at admission and 48 hours later in patients admitted to a general ICU. Patients were classified by the AKIN and KDIGO classifications at admission and 24 and 48 hours. We performed an ROC curve analysis. wbNGAL values at admission were compared in patients with sepsis and septic shock. Results. The study included 100 consecutively admitted patients (40 female) with mean age years. Thirty-three patients presented AKI at admission, and 10 more developed it in the next 48 h. Eighteen patients had AKI stage 3, 14 of them at admission. Nine patients required renal replacement therapy. According to KDIGO at admission, wbNGAL values were 78 μg/L (60-187) in stage 0 (), 263 μg/L (89-314) in stage 1 (), 484 μg/L (333-708) in stage 2 (), and 623 μg/L (231-911) in stage 3 (), for trend. Ten patients did not complete 48 hours of study: 6 of 10 were discharged (initial wbNGAL 130 μg/L (60-514)) and 4 died (773 μg/L (311-1010)). The AUROC curve of wbNGAL to predict AKI was 0.838 (95% confidence interval 0.76-0.92, ), with optimal cut-off value of 178 μg/L (sensitivity 76.7%, specificity 78.9%, ). At admission, twenty-nine patients had sepsis, of whom 20 were in septic shock. wbNGAL concentrations were 81 μg/L (60-187) in patients without sepsis, 481 (247-687) in those with sepsis, and 623.5 μg/L (361-798) in the subgroup of septic shock (). Conclusions. Whole-blood NGAL concentration at ICU admission was a good stratifier of AKI in critically ill patients. However, wbNGAL concentrations were higher in septic patients irrespective of AKI occurrence.- 2 May 2019
- Published by Wiley in Disease Markers
- Vol. 2019, 1-9
Open AccessDoes Whole-Blood Neutrophil Gelatinase-Associated Lipocalin Stratify Acute Kidney Injury in Critically Ill Patients?
Purpose. To analyse the capacity of whole-blood NGAL (wbNGAL) to stratify AKI in critically ill patients with and without sepsis. Methods. Whole-blood NGAL was measured with a point-of-care device at admission and 48 hours later in patients admitted to a general ICU. Patients were classified by the AKIN and KDIGO classifications at admission and 24 and 48 hours. We performed an ROC curve analysis. wbNGAL values at admission were compared in patients with sepsis and septic shock. Results. The study included 100 consecutively admitted patients (40 female) with mean age years. Thirty-three patients presented AKI at admission, and 10 more developed it in the next 48 h. Eighteen patients had AKI stage 3, 14 of them at admission. Nine patients required renal replacement therapy. According to KDIGO at admission, wbNGAL values were 78 μg/L (60-187) in stage 0 (), 263 μg/L (89-314) in stage 1 (), 484 μg/L (333-708) in stage 2 (), and 623 μg/L (231-911) in stage 3 (), for trend. Ten patients did not complete 48 hours of study: 6 of 10 were discharged (initial wbNGAL 130 μg/L (60-514)) and 4 died (773 μg/L (311-1010)). The AUROC curve of wbNGAL to predict AKI was 0.838 (95% confidence interval 0.76-0.92, ), with optimal cut-off value of 178 μg/L (sensitivity 76.7%, specificity 78.9%, ). At admission, twenty-nine patients had sepsis, of whom 20 were in septic shock. wbNGAL concentrations were 81 μg/L (60-187) in patients without sepsis, 481 (247-687) in those with sepsis, and 623.5 μg/L (361-798) in the subgroup of septic shock (). Conclusions. Whole-blood NGAL concentration at ICU admission was a good stratifier of AKI in critically ill patients. However, wbNGAL concentrations were higher in septic patients irrespective of AKI occurrence. - Open Access
- 7 September 2017
- Published by Elsevier in Annals of Intensive Care
- Vol. 7 (1) , 92-10
Cell-cycle arrest biomarkers in urine to predict acute kidney injury in septic and non-septic critically ill patients
- 7 September 2017
- Published by Elsevier in Annals of Intensive Care
- Vol. 7 (1) , 92-10
Open AccessCell-cycle arrest biomarkers in urine to predict acute kidney injury in septic and non-septic critically ill patients